With regards to this part of the announcement:
Pfizer have a collaboration with the Velasco team (Crizotinib). I am sure that they are very well informed about Cellmid's own collaboration with Complutense/Velasco and will be watching closely the midkine antibody development. Might be interesting both as a standalone and combinational therapy.
And it's good to see that the cannabinoid related studies continue, too.
[ATTACH] With regards to this part of the announcement: Pfizer...
-
- There are more pages in this discussion • 87 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| AN1 (ASX) Chart |
Day chart unavailable